Breakdown | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 922.57B | 815.56B | 792.37B | 834.06B | 847.90B |
Gross Profit | 242.62B | 217.87B | 213.84B | 238.56B | 231.01B |
EBITDA | 35.36B | 25.37B | 28.91B | 29.06B | 21.37B |
Net Income | 13.91B | 2.94B | 9.37B | 12.76B | 9.24B |
Balance Sheet | |||||
Total Assets | 478.25B | 449.84B | 456.47B | 454.47B | 472.07B |
Cash, Cash Equivalents and Short-Term Investments | 71.40B | 75.14B | 91.08B | 108.97B | 117.21B |
Total Debt | 104.28B | 123.56B | 133.50B | 150.69B | 150.70B |
Total Liabilities | 285.07B | 273.46B | 287.33B | 274.95B | 302.29B |
Stockholders Equity | 152.45B | 137.38B | 131.56B | 143.88B | 137.16B |
Cash Flow | |||||
Free Cash Flow | 38.48B | -744.00M | 13.99B | -1.61B | 36.09B |
Operating Cash Flow | 41.99B | 10.08B | 25.32B | 7.76B | 52.00B |
Investing Cash Flow | -30.07B | -11.12B | -18.08B | -12.36B | -15.69B |
Financing Cash Flow | -23.66B | -13.58B | -26.57B | -4.39B | 55.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €278.77B | 15.08 | 12.29% | 2.22% | 8.31% | 108.38% | |
65 Neutral | $27.01B | 15.34 | -4.27% | 3.20% | 1.00% | 3.39% | |
― | $9.02B | 30.70 | 48.74% | 2.37% | ― | ― | |
― | $2.57B | 12.38 | 4.20% | 2.74% | ― | ― | |
77 Outperform | ¥327.23B | 9.54 | 0.13% | 12.10% | 64.42% | ||
68 Neutral | ¥212.15B | 15.11 | 2.36% | 6.52% | 47.34% | ||
62 Neutral | ¥243.92B | 26.85 | 2.91% | 2.74% | 35.44% |
BIC CAMERA INC. reported a significant increase in its financial performance for the nine months ending May 31, 2025, with net sales rising by 6.1% and profit attributable to owners of the parent increasing by 43.4% compared to the previous year. The company anticipates continued growth, projecting a 4.9% increase in net sales and a 22.2% rise in profit for the full fiscal year ending August 31, 2025, reflecting strong market positioning and operational efficiency.